secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK:        0001178670
Form:       8-K
Filed at:   2022-03-17T23:59:59+00:00
Accession:  0001193125-22-077831
Event type: litigation
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Alnylam files patent infringement lawsuits against Pfizer and Moderna over mRNA COVID-19 vaccine lipids
--------------------------------------------------------------------------------

- Filed lawsuits in U.S. District Court for Delaware against Pfizer and Moderna.
- Patent No. 11,246,933 covers biodegradable cationic lipids used in mRNA COVID-19 vaccines.
- Seeking damages for infringement including a reasonable royalty; no injunction sought.
- Alnylam asserts its patented lipids are foundational to the vaccines and used without license.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178670/000119312522077831/0001193125-22-077831-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178670/000119312522077831/d336905d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-077831

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer